Emalex Biosciences

About:

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Website: https://emalexbiosciences.com

Top Investors: Fidelity, Valor Equity Partners, Horizon Technology Finance, Bain Capital Life Sciences, Paragon Biosciences

Description:

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders. The company's first development candidate Ecopipam, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome. Emalex Biosciences was founded in 2018 by Jeff Aronin.